Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Gastroenterology
Published in: Journal of Gastroenterology 14/2002

01-01-2002 | Gastroenterology and genetics—polymorphic gene and disease-caused gene

IL18 polymorphism is associated with an increased risk of Crohn’s disease

Authors: Kazuo Tamura, Yoshihiro Fukuda, Hiroko Sashio, Naohisa Takeda, Hiroko Bamba, Tadashi Kosaka, Shin Fukui, Koji Sawada, Kazutami Tamura, Masamichi Satomi, Takahiro Yamada, Takehira Yamamura, Yoshihiro Yamamoto, Jun-Ichi Furuyama, Haruki Okamura, Takashi Shimoyama

Published in: Journal of Gastroenterology | Special Issue 14/2002

Login to get access
Metadata
Title
IL18 polymorphism is associated with an increased risk of Crohn’s disease
Authors
Kazuo Tamura
Yoshihiro Fukuda
Hiroko Sashio
Naohisa Takeda
Hiroko Bamba
Tadashi Kosaka
Shin Fukui
Koji Sawada
Kazutami Tamura
Masamichi Satomi
Takahiro Yamada
Takehira Yamamura
Yoshihiro Yamamoto
Jun-Ichi Furuyama
Haruki Okamura
Takashi Shimoyama
Publication date
01-01-2002
Publisher
Springer-Verlag
Published in
Journal of Gastroenterology / Issue Special Issue 14/2002
Print ISSN: 0944-1174
Electronic ISSN: 1435-5922
DOI
https://doi.org/10.1007/BF03326428

Other articles of this Special Issue 14/2002

Journal of Gastroenterology 14/2002 Go to the issue

Gastroenterology and genetics—polymorphic gene and disease-caused gene

Association of cholecystokinin A receptor gene polymorphism with cholelithiasis and the molecular mechanisms of this polymorphism

Biotherapy and biological response modifiers for IBD

Treatment of ulcerative colitis by feeding with germinated barley foodstuff: first report of a multicenter open control trial

Biotherapy and biological response modifiers for IBD

Intestinal microflora as a therapeutic target in inflammatory bowel disease

Brain-gut relations, basics and clinics, from the viewpoint of neurogastroenterology

Brain-gut axis of the liver: the role of central neuropeptides

Biotherapy and biological response modifiers for IBD

Anti-IL-6 receptor monoclonal antibody inhibits leukocyte recruitment and promotes T-cell apoptosis in a murine model of Crohn’s disease

New treatments for gastroenterology based on genetic information

p53 gene therapy for esophageal cancer
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits